Guiding therapeutic plasma exchange for antibody‐mediated rejection treatment in lung transplant recipients – a retrospective study
- 20 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (4), 700-708
- https://doi.org/10.1111/tri.13825
Abstract
Antibody‐Mediated Rejection (AMR) due to donor‐specific antibodies (DSA) is associated with poor outcomes after lung transplantation. Currently there are no guidelines regarding the selection of treatment protocols. We studied how DSA characteristics including titers, C1q, and mean fluorescence intensity (MFI) values in undiluted and diluted sera may predict a response to therapeutic plasma exchange (TPE) and inform patient prognosis after treatment. Among 357 patients consecutively transplanted without detectable pre‐existing DSAs between 01/01/16 and 12/31/18, 10 patients were treated with a standardized protocol of five TPE sessions with IVIG. Based on DSA characteristics after treatment, all patients were divided into three groups as responders, partial responders, and non‐responders. Kaplan‐Meier Survival analyses showed a statistically significant difference in patient survival between those groups (P= 0.0104). Statistical analyses showed that MFI in pre‐TPE 1:16 diluted sera was predictive of a response to standardized protocol (R2=0.9182) and patient survival (P=0.0098). Patients predicted to be non‐responders who underwent treatment with a more aggressive protocol of 8 TPE sessions with IVIG and bortezomib showed improvements in treatment response (P=0.0074) and patient survival (P= 0.0253). Dilutions may guide clinicians as to which patients would be expected to respond to a standards protocol or require more aggressive treatment.Keywords
This publication has 36 references indexed in Scilit:
- Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Specific Autoantibody Production in Primary Thymic Cell Cultures from Early-Onset Myasthenia Gravis PatientsThe Journal of Immunology, 2014
- The mechanisms of action of plasma exchangeBritish Journal of Haematology, 2013
- Comprehensive Assessment and Standardization of Solid Phase Multiplex-Bead Arrays for the Detection of Antibodies to HLA-Drilling Down on Key Sources of VariationAmerican Journal of Transplantation, 2013
- Acute antibody-mediated rejection after lung transplantationThe Journal of Heart and Lung Transplantation, 2013
- Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in TransplantationTransplantation, 2013
- The Histopathology of Lung Allograft Dysfunction Associated With the Development of Donor-specific HLA AlloantibodiesThe American Journal of Surgical Pathology, 2012
- Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantationThe Journal of Heart and Lung Transplantation, 2010
- Immune Complex-Mediated Enhancement of Secondary Antibody ResponsesThe Journal of Immunology, 2010
- Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-κB and activator protein-1 related mechanismsMolecular Cancer Therapeutics, 2008
- Pulmonary Capillaritis in Lung Transplant Recipients: Treatment and Effect on Allograft FunctionThe Journal of Heart and Lung Transplantation, 2005